Header Logo

Connection

WILLIAM G WIERDA to Cancer Vaccines

Back to Details
This is a "connection" page, showing publications WILLIAM G WIERDA has written about Cancer Vaccines.
WILLIAM G WIERDA
Connection Strength
0.358
Cancer Vaccines
  1. The approval of lisocabtagene maraleucel in chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2024 Jul-Aug; 22(6):291-293.
    View in: PubMed
    Score: 0.155
  2. Immunotherapy of chronic lymphocytic leukemia. Expert Rev Anticancer Ther. 2001 Jun; 1(1):73-83.
    View in: PubMed
    Score: 0.125
  3. Immunologic monitoring in chronic lymphocytic leukemia. Curr Oncol Rep. 2003 Sep; 5(5):419-25.
    View in: PubMed
    Score: 0.037
  4. Gene therapy of hematologic malignancies. Semin Oncol. 2000 Oct; 27(5):502-11.
    View in: PubMed
    Score: 0.030
  5. New aspects of the treatment of chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2006 Dec; 1(4):251-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.